Abstract
Lung cancer is the worldwide leading cause of cancer-related deaths [1]. At a fundamental level, understanding the important molecular and cellular events that lead to lung cancer is critical for developing treatments to reverse this statistic. This chapter reviews the progress and limitations of our current understanding of lung cancer. It describes the initiation and progression of lung cancer from carcinogeninduced mutation of DNA to tumour formation and metastases.
Keywords: Cancer evolution, Circulating tumour cells, Driver mutation, Epithelial to mesenchymal transition, Malignant transformation, Metastases, Lung cancer, Immune evasion.
Related Journals
Current Dentistry
Current Traditional Medicine
Adolescent Psychiatry
New Emirates Medical Journal
Current Radiopharmaceuticals
Recent Patents on Anti-Cancer Drug Discovery
Current Medicinal Chemistry - Anti-Cancer Agents
Current Cancer Therapy Reviews
Clinical Cancer Drugs
Anti-Cancer Agents in Medicinal Chemistry
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents